Evaluation of plasma, erythrocytes, and brochoalveolar lavage fluid antioxidant defense system in sulfur mustard-injured patients

Clinical Toxicology

Volumn 48, Issue 3, 2010, Pages 184-192

  Jafari, Mahvash ^a   Ghanei, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant system; Lipid peroxidation; Oxidative stress; Sulfur mustard

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; MUSTARD GAS; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; HUMAN; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN DEPLETION;

ADULT; ANTIOXIDANTS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CATALASE; CHEMICAL WARFARE AGENTS; ERYTHROCYTES; FOLLOW-UP STUDIES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MUSTARD GAS; OXIDATIVE STRESS; PLASMA; SUPEROXIDE DISMUTASE; TIME FACTORS; WAR;

EID: 77951289562     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563651003623297     Document Type: Article

References (65)

1. Rice P. Sulphur mustard. Medicine 2007; 35:578-579.
2. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006; 99:273-282.
3. Merat S, Perez JP, Ruttimann M, Bordier E, Lienhard A, Lenoir B, Pats B. Acute poisoning by chemical warfare agent: sulfur mustard. Ann Fr Anesth Reanim 2003; 22:85.
4. Kehe K, Thiermann H, Balszuweit F, Eyer F, Steinritz D, Zilker T. Acute effects of sulfur mustard injury-Munich experiences. Toxicology 2009; 263:3-8.
5. Rowell M, Kehe K, Balszuweit F, Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology 2009; 263:9-11.
6. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 2007; 19:451-456.
7. Ghanei M, Mokhtari M, Mir Mohammad M, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 2004; 52:164-169.
8. Ghanei M, Akhlaghpoor S, Mohmmad MM, Aslani J. Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol 2004; 16:845-849.
9. Ghanei M, Fathi H, Mir Mohmmad M, Aslani J. Long term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 2004; 16:491-495.
10. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranian with wartime exposure to mustard agent. J Occup Environ Med 2003; 45:1136-1143.
11. Bast A, Haenen GR, Doelman CJ. Oxidants and antioxidants: state of the art. Am J Med 1991; 91:2S-13S.
12. Mates JM, Perez-Gomez C, Decastro IN. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32:595-603.
13. McCord JM. Human disease, free radicals, and the oxidant antioxidant balance. Clin Biochem 1993; 26:351-357.
14. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. J Biol Chem 1984; 249:7130-7139.
15. Dworski R. Oxidant stress in asthma. Thorax 2000; 55(Suppl. 2): S51-S53.
16. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:50-60.
17. Suzy A, Comhair A, Erzurum SC. Antioxidant responses to oxidantmediated lung diseases. Am J Physiol Lung Cell Mol Physiol 2002; 283:L246-L255.
18. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157:1666-1680.
19. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140:531-554.
20. Janssen YM, Marsh JP, Absher MP, Hemenway D, Vacek PM, Leslie KO, Borm PJ, Mossman BT. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J Biol Chem 1992; 267:10625-10630.
21. Comhair SA, Bhathena PR, Dweik RA, Kavuru M, Erzurum SC. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000; 355:624.
22. Khateri S, Ghanei M, Soroush MR, Haines D. Effects of mustard gas exposure in pediatric patients: long-term health status of mustardexposed children, 14 years after chemical bombardment of sardasht. J Burns Surg Wound Care 2003; 2:11-14.
23. Emad M. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single exposed: analysis of 197 cases. American college of chest physicians. Chest 1997; 112:734-738.
24. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol 1990; 186:209-220.
25. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem 1970; 34:30-38.
26. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70:158-169.
27. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985; 113:484-495.
28. Habig WH, Jakoby WB. Glutathione S-transferases (rat and human). Methods Enzymol 1981; 77:218-222.
29. Tietz F. Enzymic method for quantitative determination of nanogram amount of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27:502-522.
30. Ohkawa H, Ohishi N, Yagl K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-358.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
32. Van Kampen EJ, Zljlstra WG. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965; 8:141-187.
33. Pohanka M, Stetina R. Shift of oxidants and antioxidants levels in rats as a reaction to exposure to sulfur mustard. J Appl Toxicol 2009; 29:643-647.
34. Paromov V, Suntres Z, Smith M, Stone WL. Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J Burns Wounds 2007; 7:e7.
35. Koleckar V, Brojerova E, Opletal L, Jun D, Kuca K. Antioxidants, free radicals, mechanism of action and application in the therapy of the sulfur mustard caused injury. Ceska Slov Farm 2007; 56:73-76.
36. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991; 226:11632-11659.
37. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983; 52:711-760.
38. Ray R, Legere RH, Majerus BJ, Petrali JP. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol Appl Pharmacol 1995; 131:44-52.
39. Gross CL, Giles KC, Smith WJ. L-oxothiazolidine 4-carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxicity. Cell Biol Toxicol 1997; 13:167-173.
40. Werner P, Cohen G. Glutathione disulfide (GSSG) as a marker of oxidative injury to brain mitochondria. Ann NY Acad Sci 1993; 679:363-369.
41. Steinritz D, Emmler J, Hintz M, Worek F, Kreppel H, Szinicz L, Kehe K. Apoptosis in sulfur mustard treated A549 cell cultures. Life Sci 2007; 80:2199-2201.
42. Kan RK, Pleva CM, Hamllton TA, Anderson DR, Petrali JP. Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol Pathol 2003; 31:185-190.
43. Sun J, Wang YX, Sun MJ. Apoptosis and necrosis induced by sulfur mustard in HeLa cells. Zhongguo Yao Li Xue Bao 1999; 20:445-448.
44. Atkins KB, Lodhi IJ, Hurley LL, Hinshaw DB. N-acetylcysteine and endothelial cell injury by sulfur mustard. J Appl Toxicol 2000; 20S:125-128.
45. Ghanei M, Shohrati M, Jafari M, Ghaderi S, Alaeddini F, Aslani J. N-acetylcysteine improves the clinical conditions of mustard gasexposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol 2008; 103:428-432.
46. Januszewski AS, Alderson NL, Jenkins AJ, Thorpe SR, Baynes JW. Chemical modification of proteins during peroxidation of phospholipids. J Lipid Res 2005; 46:1440-1449.
47. Jafari M. Dose-and time-dependent effects of sulfur mustard on antioxidant system in liver and brain of rat. Toxicology 2000; 231:30-39.
48. Vijayaraghavan R, Kulkarni A, Pant SC, Kumar P, Rao PV, Gupta N, Gautam A, Ganesan K. Differential toxicity of sulfur mustard administered through percutaneous, subcutaneous, and oral routes. Toxicol Appl Pharmacol 2005; 202:180-188.
49. Oda Y, Kai H, Takahama K, Miyata T. Changes in lipid peroxides content and antioxidant enzyme activities on airway surface in SO2-induced bronchitic rats. Yakugaku Zasshi 1990; 110:612-616.
50. Kurata M, Suzuki M, Agar NS. Antioxidant systems and erythrocyte life-span in mammals. Comp Biochem Physiol 1993; 106B:477-487.
51. Naghii MR. Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med 2002; 167:573-575.
52. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63:152-157.
53. Comhair SAA, Erzuruma SC. Antioxidant responses to oxidantmediated lung diseases. Am J Physiol Lung Cell Mol Physiol 2002; 283:L246-L255.
54. Shohrati M, Ghanei M, Shamspour N, Babaei F, Norozi Abadi M, Jafari M, Amini Harandi A. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 2009; 0341-2040:1432-1750.
55. Rahman I. Regulation of glutathione in inflammation and chronic lung diseases. Mutat Res 2005; 579:58-80.
56. Emad A, Rezaian GR. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 1999; 115:1346-1351.
57. Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 2001; 56:36-41.
58. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16:21-26.
59. Liles WC, Klebanoff SJ. Regulation of apoptosis in neutrophils-Fas track to death? J Immunol 1995; 155:3289-3291.
60. Ghazanfari T, Sharifnia Z, Yaraee R, Pourfarzam S, Kariminia A, Mahlojirad M, Faghihzadeh S, Jalali-Nodoushan MR, Ardestani SK, Soroush MR, Amiri S, Hassan ZM, Ghavami S, Ghanei M. Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran cohort study. Int Immunopharmacol 2009; 9:1489-1493.
61. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-1456.
62. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 2003; 285:492-499.
63. Ahmad E-C, Ewan S. Transforming growth factor-b (TGF-b) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999; 18:828-837.
64. Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1160-L1164.
65. Ghanei M, Panahi Y, Mojtahedzadeh M, Hosseini Khalili A, Aslani J. Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years. Pulm Pharmacol Ther 2006; 19:148-153.